Beacon Investment Advisory Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-75
Closed -$6.01K 821
2026
Q1
$6.01K Buy
+75
New +$6.18K ﹤0.01% 684
2024
Q4
Sell
-50,178
Closed -$3.31M 253
2024
Q3
$3.31M Sell
50,178
-17,347
-26% -$1.26M 0.14% 102
2024
Q2
$6.24M Sell
67,525
-5,182
-7% -$459K 0.27% 78
2024
Q1
$6.95M Sell
72,707
-711
-1% -$59.7K 0.3% 75
2023
Q4
$5.6M Sell
73,418
-3,295
-4% -$229K 0.25% 85
2023
Q3
$5.31M Buy
76,713
+2,658
+4% +$214K 0.26% 80
2023
Q2
$6.99M Buy
74,055
+2,210
+3% +$192K 0.32% 69
2023
Q1
$5.94M Sell
71,845
-262
-0.4% -$20.6K 0.29% 77
2022
Q4
$5.38M Buy
72,107
+613
+0.9% +$47.2K 0.28% 79
2022
Q3
$5.91M Buy
71,494
+8,834
+14% +$850K 0.33% 71
2022
Q2
$5.96M Buy
62,660
+180
+0.3% +$18.6K 0.31% 75
2022
Q1
$7.36M Buy
62,480
+157
+0.3% +$17.6K 0.31% 74
2021
Q4
$8.07M Buy
62,323
+2,466
+4% +$288K 0.31% 77
2021
Q3
$6.78M Sell
59,857
-1,220
-2% -$139K 0.28% 82
2021
Q2
$6.33M Buy
61,077
+853
+1% +$80.4K 0.26% 81
2021
Q1
$5.04M Buy
60,224
+2,020
+3% +$171K 0.22% 88
2020
Q4
$5.31M Buy
58,204
+7,070
+14% +$586K 0.25% 81
2020
Q3
$4.08M Buy
51,134
+8,296
+19% +$647K 0.21% 87
2020
Q2
$2.96M Buy
42,838
+28,774
+205% +$2.04M 0.17% 99
2020
Q1
$884K Buy
+14,064
New +$1.01M 0.06% 137

Other funds holding EW

Beacon Investment Advisory Services's EW Position: Q2 2026 in Review

Beacon Investment Advisory Services sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 75 shares — an estimated $6.01K sold.

Beacon Investment Advisory Services first reported a position in EW in Q1 2020 and held it in 20 quarters. The position peaked at $8.07M in Q4 2021. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Beacon Investment Advisory Services reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Beacon Investment Advisory Services sold 75 Edwards Lifesciences shares in Q2 2026, an estimated $6.01K.
  • Beacon Investment Advisory Services first reported a position in Edwards Lifesciences in Q1 2020 and held it in 20 quarters.
  • Beacon Investment Advisory Services's Edwards Lifesciences position peaked at $8.07M in Q4 2021.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.